Medicines Marketed by Emcure Pharmaceuticals Ltd

About Emcure Pharmaceuticals Ltd

Emcure Pharmaceuticals Ltd is a prominent player in the pharmaceutical sector, specialising in the development, manufacture, and global marketing of a broad range of pharmaceutical products. The company is headquartered in Pune, Maharashtra, India, and has established a robust global presence, with operations spanning over 70 locations worldwide, including Europe, Canada, Latin America, the Middle East, Africa, Asia, Russia/CIS, and Australia.

Emcure's commitment to innovation and quality has enabled them to establish a strong foothold in various therapeutic areas, such as cardiology, pain and analgesics, HIV, gynecology, blood-related disorders, anti-infectives, nephrology, diabetes, and cancer. The company's expertise in chirality and its focus on developing differentiated products, including biologics and complex injectables, sets it apart from its competitors.

Emcure Pharmaceuticals Ltd Products

Emcure Pharmaceuticals Ltd manufactures a diverse range of pharmaceutical products, including Active Pharmaceutical Ingredients (APIs), branded generic products, chiral molecules, biologics, vitamins, minerals, and nutrients. The company's product portfolio caters to a wide array of therapeutic areas, with a notable presence in gynecology, where Emcure is the largest pharmaceutical company in India, and in HIV antivirals, where it ranks 1st in terms of domestic sales.

Emcure's state-of-the-art manufacturing facilities adhere to global safety and efficacy standards, including Good Manufacturing Practices (GMP), ensuring the production of high-quality and reliable treatments. The company's strong research and development focus, driven by a team of approximately 500 qualified scientists and industry leaders, enables continuous innovation and the launch of new products, such as emcutix, which strengthens their derma portfolio. Emcure's strategic partnerships with multinational companies and its widespread supply chain across over 70 countries further contribute to its global reach and impact in the pharmaceutical industry.